CIK 0001689375
- Accelerated filer
- Smaller reporting company
- Emerging growth company
Entrada Therapeutics, Inc.
Sign in to watch- Ticker
- TRDA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 813983399
- Phone
- +1 857-305-1825
- Business address
- ONE DESIGN CENTER PLACE, SUITE 17-500, BOSTON, MA, 02210
- Former names
- CycloPorters, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $7,200,939
- in 8 filings
Net −$7,200,939. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 21 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-09-27 | KREHER NERISSA Chief Medical Officer | Option exercise | +2,403 | $2.10 | $5K | 23,119 |
| 2022-09-27 | KREHER NERISSA Chief Medical Officer | Sale | −2,403 | $15.31 | $37K | 20,716 |
| 2022-09-27 | KREHER NERISSA Chief Medical Officer | Option exercise · Stock Option (Right to Buy) | −2,403 | 19,154 | ||
| 2022-09-26 | Doshi Dipal President and CEO | Sale | −2,795 | $15.22 | $43K | 212,627 |
| 2022-09-26 | Doshi Dipal President and CEO | Sale | −288 | $16.30 | $5K | 212,339 |
| 2022-09-26 | KREHER NERISSA Chief Medical Officer | Option exercise | +3,068 | $2.10 | $6K | 23,784 |
| 2022-09-26 | KREHER NERISSA Chief Medical Officer | Sale | −2,768 | $15.22 | $42K | 21,016 |
| 2022-09-26 | KREHER NERISSA Chief Medical Officer | Sale | −300 | $16.33 | $5K | 20,716 |
| 2022-09-26 | KREHER NERISSA Chief Medical Officer | Option exercise · Stock Option (Right to Buy) | −3,068 | 21,557 | ||
| 2022-09-26 | Dowden Nathan J Chief Operating Officer | Sale | −1,329 | $15.32 | $20K | 63,026 |
| 2022-09-26 | Dowden Nathan J Chief Operating Officer | Sale | −215 | $16.25 | $3K | 62,811 |
| 2022-09-23 | Doshi Dipal President and CEO | Sale | −1,023 | $15.07 | $15K | 215,422 |
| 2022-09-23 | KREHER NERISSA Chief Medical Officer | Option exercise | +939 | $2.10 | $2K | 21,655 |
| 2022-09-23 | KREHER NERISSA Chief Medical Officer | Sale | −939 | $15.09 | $14K | 20,716 |
| 2022-09-23 | KREHER NERISSA Chief Medical Officer | Option exercise · Stock Option (Right to Buy) | −939 | 24,625 | ||
| 2022-09-23 | Dowden Nathan J Chief Operating Officer | Sale | −1,018 | $15.07 | $15K | 64,355 |
| 2022-09-21 | Doshi Dipal President and CEO | Sale | −3,402 | $15.12 | $51K | 216,445 |
| 2022-09-21 | KREHER NERISSA Chief Medical Officer | Option exercise | +3,341 | $2.10 | $7K | 24,057 |
| 2022-09-21 | KREHER NERISSA Chief Medical Officer | Sale | −3,341 | $15.08 | $50K | 20,716 |
| 2022-09-21 | KREHER NERISSA Chief Medical Officer | Option exercise · Stock Option (Right to Buy) | −3,341 | 25,564 |
Page 21 of 26 · 517 trades